ATE221786T1 - Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus - Google Patents

Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus

Info

Publication number
ATE221786T1
ATE221786T1 AT95917797T AT95917797T ATE221786T1 AT E221786 T1 ATE221786 T1 AT E221786T1 AT 95917797 T AT95917797 T AT 95917797T AT 95917797 T AT95917797 T AT 95917797T AT E221786 T1 ATE221786 T1 AT E221786T1
Authority
AT
Austria
Prior art keywords
protection against
against human
virus infections
deficiency virus
human immuno
Prior art date
Application number
AT95917797T
Other languages
English (en)
Inventor
Barton F Haynes
Thomas J Palker
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE221786T1 publication Critical patent/ATE221786T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT95917797T 1994-04-29 1995-04-28 Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus ATE221786T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23530594A 1994-04-29 1994-04-29
PCT/US1995/005465 WO1995029700A1 (en) 1994-04-29 1995-04-28 Synthetic vaccine for protection against human immunodeficiency virus infection

Publications (1)

Publication Number Publication Date
ATE221786T1 true ATE221786T1 (de) 2002-08-15

Family

ID=22884945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95917797T ATE221786T1 (de) 1994-04-29 1995-04-28 Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus

Country Status (10)

Country Link
EP (1) EP0762895B1 (de)
JP (1) JPH09512561A (de)
AT (1) ATE221786T1 (de)
AU (1) AU707894B2 (de)
CA (1) CA2189045A1 (de)
DE (1) DE69527708T2 (de)
DK (1) DK0762895T3 (de)
ES (1) ES2177648T3 (de)
PT (1) PT762895E (de)
WO (1) WO1995029700A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014436A1 (en) * 1995-10-20 1997-04-24 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
MXPA01011499A (es) 1999-05-13 2002-06-04 American Cyanamid Co Formulaciones de combinacion de adyuvantes.
IL150961A0 (en) 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
BR0114094A (pt) 2000-09-22 2003-07-22 Univ Duke Imunógeno
US7033593B2 (en) 2000-09-22 2006-04-25 Duke University Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
EP1411770A4 (de) 2001-07-05 2006-05-10 Chiron Corp Polynukleotide, die für antigene hiv-polypeptide des c-typs codieren, polypeptide und ihre verwendung
US7172761B2 (en) 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7153509B2 (en) 2001-11-07 2006-12-26 Duke University Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
US7195768B2 (en) 2001-11-07 2007-03-27 Duke University Polyvalent immunogen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013548A (en) * 1987-09-08 1991-05-07 Duke University Production of antibodies to HIV
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV

Also Published As

Publication number Publication date
EP0762895B1 (de) 2002-08-07
AU2372695A (en) 1995-11-29
DK0762895T3 (da) 2002-09-02
PT762895E (pt) 2002-11-29
EP0762895A1 (de) 1997-03-19
JPH09512561A (ja) 1997-12-16
WO1995029700A1 (en) 1995-11-09
EP0762895A4 (de) 1997-08-27
AU707894B2 (en) 1999-07-22
DE69527708D1 (de) 2002-09-12
CA2189045A1 (en) 1995-11-09
DE69527708T2 (de) 2003-04-30
ES2177648T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
WO1993015205A3 (en) Synthetic haemophilus influenzae conjugate vaccine
FI950405A (fi) Heikosti immunogeenisten antigeenien ja synteettisten peptidikantajien konjugaatit sekä niitä sisältävät rokotteet
SE9102976D0 (sv) Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider
DE69535018D1 (de) Papillomavirus vakzine
ATE221786T1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
CY1105010T1 (el) Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου
Macfarlan et al. Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain
AU4826493A (en) Anti-feline immunodeficiency virus (fiv) vaccines
EP0830456A4 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
GB8912651D0 (en) Peptide fragments of hiv
ATE302016T1 (de) Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
KR920004422A (ko) Hiv의 주요 중화 결정인자
BR9202575A (pt) Polipeptideo imunogenico,molecula de dna isolada,vetor,processos para produzir um polipeptideo,um vetor,um virus e um microorganismo,vacina,uso de polipeptideo,vetor,virus,microorganismo e processo para proteger um individuo contra coccidiose
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
KR920002629A (ko) B형 간염 코어 항원의 아미노산 잔기 서열
KR910011897A (ko) 말라리아 백신
CY1105176T1 (el) Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας
CA1337115C (en) Vaccination against rabies-related diseases
AU4832097A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
DE60022995D1 (de) Impfstoff
ES2065254A1 (es) Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
RU95121713A (ru) Способ одновременной профилактики менингококковой инфекции, дифтерии, брюшного тифа, натуральной оспы, гриппа и вирусного гепатита

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee